Weight gain after 12 months of switching to bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed HIV patients.
Sign Up to like & getrecommendations! Published in 2023 at "AIDS research and human retroviruses"
DOI: 10.1089/aid.2022.0130
Abstract: Recent studies suggest that the introduction of antiretroviral agents such as integrase strand transfer inhibitors (INSTI) may lead to more weight gain in patients living with HIV (PLHIV). In this retrospective observational study, we report… read more here.
Keywords: months switching; suppressed hiv; virologically suppressed; weight gain ... See more keywords